In the first swim session of the induction phase of CDM, mice usually show a mean immobility time between 190 s and 230 s, which constantly rises with every additional swim session (Figure 1A). This increase is more pronounced in the first 3 days and reaches a plateau-like phase during the last 2-3 days. The immobility-time measured on day 5 remains stable over up to 4 weeks, indicating stable behavioral despair. The antidepressant potency of an intervention can be evaluated by treating the animal between the last day of the induction phase and the test day. Note that the absolute scoring time during the swim sessions is quite subjective and depends on the experimenter, age, sex, and the mouse-line used. However, the relative difference between the sessions is fairly stable with only small interrater differences.
In Figure 1, several representative treatments are shown. Imipramine, sleep deprivation, and ketamine significantly reduced the immobility-time, while sleep deprivation combined with a recovery sleep did not show a significant change of the depressive-like phenotype. These results are concordant with an anti-depressive potency of the applied treatments and similar to effects observed in human patients. The treatment involved ingestion of imipramine 20 mg/kg/day for 3 weeks via drinking water, 3 mg/kg of ketamine by a single intraperitoneal injection 24 h before testing, and sleep deprivation for 6 h before testing.
Depending on the research question, various representations may be displayed. A representation of absolute values can give a real data overview and allows a good evaluation of the induction phase and of a single treatment (Figure 1A,D). However, the differences of various treatments cannot be directly compared; hence each treatment group has different mean values of immobility-time on day 5. Therefore, it is recommended to use the representation of normalized mean values in this case (Figure 1B). A reduced representation may be chosen due to space limitations (Figure 1C). Note that it is mandatory to show at least the results of day 1, day 5, and the test day.

Figure 1: Successful results in absolute and normalized values. (A) Successful induction of a depressed-like state in 30 mice can be observed. Each dot represents the immobility time of a single animal on a specific day and bars represent the mean values of the tested animals. Immobility time is represented for each day of the induction phase (day 1 to day 5) and for the test day (after the dotted line) with or without treatment. Note that in this sample, a significant increase can be observed between day 1 and day 2. In some cases, significance levels are first achieved between day 1 and day 3. For the continuation of the experiment, a statistically significant increase between day 1 and day 5 is mandatory. Note the typical ceiling effect (increase between days 1, 2, and 3, compared to the difference between days 4 and 5). Between day 5 and the test days, animals were housed for 4 weeks in their home cages, either without further treatment (CDM) or treated with imipramine (Imip.); sleep deprivation (SD); sleep deprivation and recovery sleep (RS), and ketamine (Ket). (B) Exemplary time course of the performance of individual animals are given for each day. (C) Normalized representation of the same results already shown in Figure 1A. The immobility time of each animal and day was normalized to its corresponding immobility time on day 5 and expressed in percentage. Post-treatment values of different groups can be better displayed and compared using this approach. (D) Representation of normalized values for day 1, day 5, and the test day (CDM). After a successful proof of concept study, evaluation time points may be reduced to day one, day five and the test day. These time points are needed because a significant increase between day 1 and day 5 is necessary to demonstrate a successful induction, and day 5 needs to be compared to the test day to give a statement on treatment efficacy. (E) Comparison of the immobility time of three different mouse lines: Wildtype (WT) shows a successful induction; an exemplary resilient-line (RL) shows a significantly decreased depression-like behavior on the first three days and on the test day. One-way ANOVA with Bonferroni post hoc test: ∗/#p < 0.05, ∗∗/##p < 0.01, ∗∗∗/###p < 0.001, ∗∗∗∗/####p < 0.0001. (#indicate difference to mean values of day 1, ∗indicate difference to mean values of day 5 in Figure 1A,C and to WT mouse line in Figure 1E). Data are expressed as the means ± SEM. Please click here to view a larger version of this figure.
In case of an unchanged immobility time during all the 5 days (Figure 2), the applied stress was not able to change the behavior relevantly, and no treatment effects can be evaluated; animals need to be sacrificed and must not be used further.

Figure 2: Unsuccessful results. A representation of an ineffective induction is shown in the figure. Note that no significant increase in immobility time between day 1 and day 5 occurs. Therefore, criteria for continuation of the experiment were not achieved, and no further prolongation is rational (in this case, only male mice were tested, and after retrospective investigation, it was found that they were not littermates). Please click here to view a larger version of this figure.
Further read-out methods must be used to describe a broader view of the behavioral despair of the animals. A variety of behavioral tests, electrophysiological measurements, and molecular assessments of stress-induced changes are available. Exemplary results for Tail Suspension Test (TST), with CDM, imipramine and ketamine treatment, Nose-poke-Sucrose Preference Test (NPSPT), and assessment of long-term potentiation using the patch-clamp technique are given in Figure 3. These results encourage using the CDM induction phase as a general tool for the induction of behavioral despair. For further details of the used techniques (TST, NPSPT, LTP-assessment) see9,10,17,20.

Figure 3: Additional results with CDM mice. (A) An exemplary representation of the effects of CDM in the Tail Suspension Test. Mice were suspended by their tail, and the time spent immobile was recorded (for methodological details see9). Each dot represents the immobility time of a single animal, and bars represent the mean values of the tested animals. One-way ANOVA with Bonferroni post hoc test: ∗∗∗p < 0.001. Data are expressed as the means ± SEM. (B) Representative results of the recently established nose-pokes sucrose preference test in CDM mice. In this task, sucrose preference was measured with gradual increasing effort to reach the sucrose bottle (number of nosepokes) (for methodological details see10). Note that sucrose preference was decreased in CDM and that the difference between CDM and control mice gradually increases with the effort (mean values of nose pokes on each day indicated as Nspk1-7) mice had to apply to drink the sweet solution. Two-way ANOVA with Bonferroni post hoc test: ∗∗p < 0.01, ∗∗∗p < 0.001. Data are expressed as the means ± SEM. (C) CDM-dependent changes in long-term synaptic plasticity are presented as changes of mean values of EPSPs after the application of an associative LTP induction protocol in hippocampal brain slices of WT mice. Data were obtained by stimulation of the CA3-CA1 synapse (for details see17,20). Unpaired t-test, ∗∗p < 0.01, data are expressed as the means ± SEM. Please click here to view a larger version of this figure.
Supplementary Material. Please click here to download this File.